340255 <common-name>N-(2-chloroethyl)-n-(2-chloro-1-phenylethyl)-[(2r,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxyphosphonamidic acid</common-name> <description>N-(2-chloroethyl)-n-(2-chloro-1-phenylethyl)-[(2r,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxyphosphonamidic acid is a chemical compound with the formula C24H32Cl2NO12P. With an average molecular weight of 628.40 g/mol, N-(2-chloroethyl)-n-(2-chloro-1-phenylethyl)-[(2r,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxyphosphonamidic acid is a heavy molecule.</description> <cas>53115-84-7</cas> <pubchem-id>3040942</pubchem-id> <chemical-formula>C24H32Cl2NO12P</chemical-formula> <weight>628.4</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-30T23:46:27Z</created-at> <updated-at type="dateTime">2026-08-30T23:46:27Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC(=O)OCC1C(C(C(C(O1)OP(=O)(N(CCCl)C(CCl)C2=CC=CC=C2)O)OC(=O)C)OC(=O)C)OC(=O)C</moldb-smiles> <moldb-formula>C24H32Cl2NO12P</moldb-formula> <moldb-inchi>InChI=1S/C24H32Cl2NO12P/c1-14(28)34-13-20-21(35-15(2)29)22(36-16(3)30)23(37-17(4)31)24(38-20)39-40(32,33)27(11-10-25)19(12-26)18-8-6-5-7-9-18/h5-9,19-24H,10-13H2,1-4H3,(H,32,33)/t19?,20-,21-,22+,23-,24-/m1/s1</moldb-inchi> <moldb-inchikey>YLNJGYPPJARVPQ-PDYRQOBPSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">627.1039178</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>1.5</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM336148</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>N-(2-chloroethyl)-n-(2-chloro-1-phenylethyl)-[(2r,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxyphosphonamidic acid</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organic acids and derivatives</superklass> <klass>Carboxylic acids and derivatives</klass> <subklass>Tetracarboxylic acids and derivatives</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0290670</sync-id> <structure-inchikey>YLNJGYPPJARVPQ-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>40000000000000200000800000000000000010000000000080100000000000000000000000000000000000000000080004000000000000000000000002100000004000040000080000000000200000001020820000000100000000000000000000000000010000000002000000004000000020000000000800000100000000500810000040000000800024000200800000000040100108000000000000000000000000002010000000000400080000000000000000008000000000000000040000000000000400000000000000000000000010000008000000000200000000000000000000020000000040000100000440000003000000400020000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAoAAAAKQAAAIABBgBgAAAAAQMGACgAAAAD BAgAKAAAAAMCCAAoAAAAAwIGAGAAAAACAgYAYAAAAAMBBgBgAAAAAwEGAGAA AAADAQYAYAAAAAMBBgBgAAAAAwEIACAAAAACCAAgAAAAAg8AIAAAAAUIACgA AAADAgcAIAAAAAMGAGAAAAACAgYAYAAAAAICEQAgAAAAAQYAYAAAAAMBBgBg AAAAAgIRACAAAAABBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQGgAAAAD AwEGQGgAAAADAwEGQGgAAAADAwEIAGAAAAABAQgAKAAAAAMCBgAoAAAAAwQI ACgAAAADAgYAYAAAAAEDCAAoAAAAAwIGACgAAAADBAgAKAAAAAMCBgBgAAAA AQMIACgAAAADAgYAKAAAAAMECAAoAAAAAwIGAGAAAAABAwsAAQABAigCAQMg AwQABAUABQYABgcABwgACAkACQoACQsACwwADA0IAgwOAA4PAA8QABARAA4S ABITABMUABIVABUWaAwWF2gMFxhoDBgZaAwZGmgMDBsACBwAHB0gHR4oAh0f AAcgACAhICEiKAIhIwAGJAAkJSAlJigCJScACgUAGhVoDEICAAAABgUKCQgH BgYWFxgZGhUXBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:40:35Z</structure-indexed-at> </compound>